cdmo.directory
← Compare landing

Maravai LifeSciences vs Samsung Biologics

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/maravai/samsungbiologics

CategoryMaravai LifeSciencesSamsung Biologics
Listed sitecdmocdmo
SummaryLeading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.
Services
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • Vaccine Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Quality Control Testing
  • Process Development
  • Cell-Line Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Technology Transfer
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • mRNA Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Quality Control Testing
  • Biologics Development & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Vial Filling
  • Stability Testing & Storage
  • Formulation Development
  • Vaccine Manufacturing
  • ADC Payload & Linker Synthesis
  • Lipid Nanoparticle (LNP) Formulation
  • Prefilled Syringe (PFS) Filling
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Oligonucleotide
  • mRNA
  • Gene Therapy
  • Vaccine
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • mRNA
  • Vaccine
Indications
  • Oncology
  • Neurology
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Oncology
LocationsData not yet provided.
  • Bio Campus I, South Korea
  • Bio Campus II, South Korea
  • Headquarters / Bio Campus I, Incheon, Yeonsu-gu, Republic of Korea
  • Bio Campus II, Incheon, Yeonsu-gu, Republic of Korea
  • ADC Plant, Incheon, Yeonsu-gu, Republic of Korea
  • Samsung Biologics America, United States
  • Samsung Biologics Japan Office, Japan
  • Headquarters
Certifications
  • ISO · Identifier: ISO-9001:2015
  • ISO · Identifier: ISO-9001:2015
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.